Hyperostosis-hyperphosphatemia syndrome (HHS) is another clinical feature of GALNT3 deficiency; however, as concluded by Ichikawa et al. [49], we consider HFTC and HHS to be a continuous spectrum of the same disease and we describe both conditions as HFTC in this review. The gene discussed is GALNT3; the disease is hypotrichosis 1.